# Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies

> **NCT00747071** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Clostridium Difficile-Associated Diarrhea

## Interventions

- **DRUG:** Colostrum

## Key facts

- **NCT ID:** NCT00747071
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2012-11
- **Final completion:** 2013-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsors decision
- **Last updated:** 2012-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747071, "Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00747071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*